On-line ABCR study

If you have RRMS or Progressive MS and either have started within the last three weeks, or plan to start soon, treatment with Avonex, Betaseron, Copaxone or Rebif, you might be interested in partcipating in a new online study sponsored by the Maimonides Multiple Sclerosis Care Center in Brooklyn. The study will look at the reasons why people may or may not keep up with an injectible drug regimen. Participation involves completing an online questionnaire that should take about 10-15 minutes, and responding to an e-mail in six months.For more information e-mail Dr. Cira Fraser at cirafraser@si.rr.com or cfraser@monmouth.edu. Indicate which injectable medication you plan to take, or recently started to take, as well as the date you plan to start/started.